Master TSH, free T4, free T3, and thyroid antibodies. Diagnose hypothyroidism and hyperthyroidism for ASCP BOC chemistry.
ASCPprep.com | Clinical Chemistry
Chapter 12 โ The Thyroid Gland
ASCP Board Exam ยท Lab-Focused Study Guide
Methods ยท Clinical Interpretation ยท Pre-analytical Variables ยท Practice Questions
SECTION 1 โ Priority Map & Quick Foundation
| Topic | Priority | Why It’s Tested |
|---|---|---|
| TSHโfTโ feedback & interpretation patterns | HIGH | The #1 thyroid concept on the exam โ every disorder is a TSH/fTโ pattern |
| Hypothyroidism (Hashimoto, central, subclinical) | HIGH | Most common disorder; anti-TPO and pattern recognition heavily tested |
| Hyperthyroidism / Graves & thyrotoxicosis | HIGH | TSI/TRAb, T3 toxicosis, thyroid storm โ classic vignettes |
| Free vs total hormone & binding-protein effects | HIGH | Pregnancy/estrogen โTBG traps; free hormone hypothesis |
| TSH assay generations & functional sensitivity | MEDIUM | 3rd-gen = 0.01 mIU/L; CV<20% definition |
| Hormone synthesis (NIS, TPO, Tg, organification) | MEDIUM | Method/defect questions (perchlorate discharge, Pendrin) |
| Thyroglobulin & calcitonin as tumor markers | MEDIUM | Tg (differentiated cancer) vs calcitonin (medullary) โ don’t mix up |
| Drugs (amiodarone, lithium, phenytoin, propranolol) | MEDIUM | Amiodarone 37% iodine; interference patterns |
| Embryology & anatomy | LOW | Foramen cecum, C-cell origin โ occasional recall items |
๐ฏ Where to spend your time
Master the TSH/fTโ interpretation grid first โ it unlocks half the chapter. Then lock in Hashimoto vs Graves antibodies and the free vs total binding-protein traps. Skim embryology and deep synthesis biochemistry; know only the names that map to a defect test (NIS, TPO, Pendrin, perchlorate).
Master the TSH/fTโ interpretation grid first โ it unlocks half the chapter. Then lock in Hashimoto vs Graves antibodies and the free vs total binding-protein traps. Skim embryology and deep synthesis biochemistry; know only the names that map to a defect test (NIS, TPO, Pendrin, perchlorate).
Quick Foundation (zero-to-clear)
- The thyroid makes two hormones: Tโ (thyroxine, the reservoir) and Tโ (triiodothyronine, the active one). Most active Tโ is made outside the gland by removing one iodine from Tโ.
- The pituitary releases TSH to tell the thyroid “make more.” Hormone levels feed back to shut TSH off โ a thermostat.
- TSH moves opposite to thyroid hormone in primary disease: gland fails โ hormone low โ TSH high (hypothyroid); gland overactive โ hormone high โ TSH low (hyperthyroid).
- Over 99% of hormone rides on carrier proteins (mainly TBG). Only the tiny free fraction is active โ so anything that changes carrier proteins fakes out total measurements.
- Iodine is the raw material. Too little โ goiter; sudden too much โ temporary shutdown (Wolff-Chaikoff).
- Most thyroid disease is autoimmune: Hashimoto (destroys โ hypo) and Graves (stimulates โ hyper).
๐ง Analogy
Think of TSH as a thermostat and thyroid hormone as room temperature. If the room is cold (low hormone), the thermostat cranks up (high TSH). If the room is hot (high hormone), the thermostat shuts off (low TSH). When the thermostat itself is broken (pituitary problem), the readings stop making sense โ that’s central disease.
Think of TSH as a thermostat and thyroid hormone as room temperature. If the room is cold (low hormone), the thermostat cranks up (high TSH). If the room is hot (high hormone), the thermostat shuts off (low TSH). When the thermostat itself is broken (pituitary problem), the readings stop making sense โ that’s central disease.
| Concept | Plain-English Explanation |
|---|---|
| TSH | Pituitary’s “make hormone” signal; the most sensitive single screening test |
| Tโ vs Tโ | Tโ = stored/inactive bulk; Tโ = active worker made mostly by deiodinating Tโ |
| Free vs Total | Free = unbound, active; Total = free + protein-bound (skewed by TBG changes) |
| Primary vs Central | Primary = gland problem (TSH compensates); Central = pituitary/hypothalamus problem (TSH inappropriate) |
| Autoimmune | Hashimoto antibodies destroy; Graves antibodies stimulate |
SECTION 2 โ Core Analytes & Methods
TSH (Thyroid-Stimulating Hormone / Thyrotropin)
| Feature | Details |
|---|---|
| Definition | Anterior pituitary glycoprotein; ฮฑ-subunit shared with hCG, FSH, LH; unique ฮฒ-subunit confers specificity |
| Normal range | ~0.4โ4.0 mIU/L (assay/population dependent) |
| Mechanism of change | Rises when thyroid hormone falls (loss of negative feedback); falls when hormone is high. Log-linear inverse relationship with fTโ |
| Clinical significance | Single most sensitive screen for primary thyroid disease; a small fTโ change causes a large TSH change |
| Assay method | Two-site immunometric (“sandwich”) assay. 3rd generation = functional sensitivity 0.01 mIU/L (CV < 20%) |
| Key interferences | Heterophile/biotin interference; macro-TSH (falsely high); inappropriate in central disease |
TSH is the workhorse screen, but it is only valid when the pituitaryโthyroid axis is intact. In central disease TSH can be low, normal, or even mildly high yet biologically inactive โ so it cannot stand alone.
๐งช Pre-analytical โ TSH
Serum (SST) or plasma. Diurnal variation: TSH peaks late night/early morning, lowest mid-afternoon โ standardize draw time for borderline results. Recent biotin supplements can falsely lower TSH in some immunoassays (hold ~2 days). Stable refrigerated; freeze for delay.
Serum (SST) or plasma. Diurnal variation: TSH peaks late night/early morning, lowest mid-afternoon โ standardize draw time for borderline results. Recent biotin supplements can falsely lower TSH in some immunoassays (hold ~2 days). Stable refrigerated; freeze for delay.
Thyroxine (Tโ) โ Total & Free
| Feature | Details |
|---|---|
| Tissue source | Thyroid follicular cells (only source of Tโ); the main secretory product |
| Transport | ~99.97% protein-bound: TBG (main) > transthyretin (TTR) > albumin; only ~0.03% free |
| Mechanism of change | Total Tโ tracks both gland output AND binding-protein quantity; free Tโ tracks true thyroid status |
| Clinical significance | fTโ confirms/stages disease after abnormal TSH; the storage/reservoir hormone |
| Assay method | fTโ: analog immunoassay (routine) vs equilibrium dialysis / ultrafiltration (gold standard) |
| Key interferences | โTBG (estrogen/pregnancy) raises total Tโ with normal free Tโ; FDH falsely raises total (and some free) Tโ |
๐งช Pre-analytical โ Tโ
Serum preferred. Estrogen, pregnancy, OCPs raise TBG โ high total Tโ but normal fTโ and TSH (euthyroid). Androgens, nephrotic syndrome, malnutrition lower TBG. Heparin can falsely raise fTโ in vitro by releasing free fatty acids that displace Tโ. Avoid biotin interference.
Serum preferred. Estrogen, pregnancy, OCPs raise TBG โ high total Tโ but normal fTโ and TSH (euthyroid). Androgens, nephrotic syndrome, malnutrition lower TBG. Heparin can falsely raise fTโ in vitro by releasing free fatty acids that displace Tโ. Avoid biotin interference.
Triiodothyronine (Tโ)
| Feature | Details |
|---|---|
| Source | ~20% direct thyroid secretion; ~80% from peripheral 5′-deiodination of Tโ (D1, D2) |
| Activity | The active hormone โ higher affinity for nuclear THR than Tโ |
| Clinical significance | Key for diagnosing T3 toxicosis (suppressed TSH, normal fTโ, high fTโ/tTโ) |
| Reverse Tโ (rTโ) | Inactive; โ in non-thyroidal illness as D3 shunts Tโ away from active Tโ |
| Key interferences | Falls in non-thyroidal illness (“low T3 syndrome”) โ do NOT order in sick inpatients to screen thyroid |
๐งช Pre-analytical โ Tโ
Tโ is the first hormone to fall in non-thyroidal (euthyroid sick) illness โ low Tโ in a hospitalized patient usually reflects illness, not thyroid disease. Avoid thyroid testing in acute illness unless clearly indicated.
Tโ is the first hormone to fall in non-thyroidal (euthyroid sick) illness โ low Tโ in a hospitalized patient usually reflects illness, not thyroid disease. Avoid thyroid testing in acute illness unless clearly indicated.
Thyroglobulin (Tg) & Calcitonin โ Tumor Markers
| Feature | Thyroglobulin (Tg) | Calcitonin |
|---|---|---|
| Source | Follicular cells (colloid scaffold protein) | Parafollicular (C) cells โ neural crest origin |
| Marker for | Differentiated (papillary/follicular) thyroid cancer follow-up after thyroidectomy | Medullary thyroid carcinoma (MTC) diagnosis & monitoring |
| Key caveat | Must report with anti-Tg antibody status โ anti-Tg causes false-low Tg | Linked to RET proto-oncogene; part of MEN2 |
| Method | Immunoassay (ยฑ LC-MS/MS when antibodies present) | Immunoassay |
๐งช Pre-analytical โ Tg
Always measure anti-Tg antibodies alongside Tg. Endogenous anti-Tg antibodies cause clinically dangerous false-negative Tg results in immunometric assays (a recurrence can be missed). Tg only meaningful after total thyroidectomy/ablation.
Always measure anti-Tg antibodies alongside Tg. Endogenous anti-Tg antibodies cause clinically dangerous false-negative Tg results in immunometric assays (a recurrence can be missed). Tg only meaningful after total thyroidectomy/ablation.
Synthesis Machinery (defect-test relevance)
| Player | Role | Exam handle |
|---|---|---|
| NIS (SLC5A5) | Basolateral pump: iodide into cell against gradient | Defect โ no uptake; perchlorate discharge negative |
| Pendrin (SLC26A4) | Apical iodide transport into lumen | Pendred syndrome (goiter + deafness) |
| TPO | Iodinates tyrosines + couples to form Tโ/Tโ (needs HโOโ) | Target of anti-TPO antibodies; organification defect |
| Thyroglobulin (Tg) | Scaffold for synthesis & colloid storage | Also the cancer marker |
| DUOX1/DUOX2 | Generate HโOโ at apical membrane | Required for organification |
SECTION 3 โ Memory Hooks & Pattern Triggers
๐ “TSH goes the OPPOSITE way” (primary disease)
Gland fails โ hormone โ โ TSH โ (hypo). Gland overworks โ hormone โ โ TSH โ (hyper). If TSH and fTโ move the same direction โ think central disease, TSHoma, or RTH.
Gland fails โ hormone โ โ TSH โ (hypo). Gland overworks โ hormone โ โ TSH โ (hyper). If TSH and fTโ move the same direction โ think central disease, TSHoma, or RTH.
๐ Antibody mnemonic โ “TPO Trashes, TSI Turbocharges”
Anti-TPO โ Hashimoto (Trashes the gland โ hypo). TSI/TRAb โ Graves (Turbocharges the receptor โ hyper).
Anti-TPO โ Hashimoto (Trashes the gland โ hypo). TSI/TRAb โ Graves (Turbocharges the receptor โ hyper).
๐ Tumor markers โ “Tg = Thyroid-cancer (differentiated); Calcitonin = C-cells (medullary)”
Both start with the cell of origin. Follicular cell โ Thyroglobulin. C cell โ Calcitonin โ RET.
Both start with the cell of origin. Follicular cell โ Thyroglobulin. C cell โ Calcitonin โ RET.
๐ Thyroid storm โ “Five Bs”
Block synthesis (thionamide) ยท Block release (iodine, given AFTER thionamide) ยท Block TโโTโ conversion (PTU, propranolol, steroids) ยท Beta-blocker ยท Block enterohepatic circulation (cholestyramine).
Block synthesis (thionamide) ยท Block release (iodine, given AFTER thionamide) ยท Block TโโTโ conversion (PTU, propranolol, steroids) ยท Beta-blocker ยท Block enterohepatic circulation (cholestyramine).
Pattern Trigger Table
| If you seeโฆ | Thinkโฆ | Becauseโฆ |
|---|---|---|
| High total Tโ, normal TSH, pregnant/on estrogen | โTBG, euthyroid (not hyperthyroid) | Estrogen raises binding protein; free hormone & TSH stay normal |
| High TSH + normal fTโ | Subclinical hypothyroidism | Gland compensating; hormone still in range |
| Low TSH + normal fTโ + high fTโ | T3 toxicosis | Excess Tโ suppresses TSH before fTโ rises |
| Low fTโ + low/normal TSH | Central hypothyroidism | Pituitary not responding to low hormone |
| High fTโ + non-suppressed TSH | TSHoma or RTH-ฮฒ | Inappropriate TSH secretion or receptor resistance |
| Low Tโ, low/normal everything in a sick inpatient | Non-thyroidal illness | D3 โ rTโ; don’t diagnose thyroid disease acutely |
| Falsely low Tg in cancer follow-up | Anti-Tg antibody interference | Antibodies block the immunoassay |
Commonly Confused โ Side by Side
| Hashimoto | Graves | |
|---|---|---|
| Direction | Hypothyroid | Hyperthyroid |
| Antibody | Anti-TPO (ยฑ anti-Tg) | TSI / TRAb (stimulating) |
| Mechanism | T-cellโmediated destruction | Antibody stimulates TSH receptor |
| Clue | Painless goiter, fatigue | Ophthalmopathy, pretibial myxedema, acropachy |
| TSH / fTโ | โTSH / โfTโ | โTSH / โfTโ |
Diagnostic Window โ Time-Based Markers
| Marker / event | Onset | Peak | Duration | Best clinical use |
|---|---|---|---|---|
| Neonatal TSH surge (cold stress) | Within 30 min of birth | ~30 min | Falls over 24โ48 h | Time newborn screen โฅ24โ48 h to avoid false positives |
| Levothyroxine โ steady state | Days | โ | ~6 weeks | Recheck TSH no sooner than 6 weeks after dose change |
| Postpartum thyroiditis | Weeks after delivery | Hyper then hypo phase | Within 12 months | Transient; usually resolves |
| Amiodarone effect | Weeks | โ | Half-life 40 ยฑ 10 days | Thyroid effects persist long after stopping |
SECTION 4 โ Diagnostic Flowcharts
โ Differential โ Fatigue, weight gain, cold intolerance
| Step | Path |
|---|---|
| Start | Patient: fatigue, weight gain, cold intolerance โ order TSH |
| โ | TSH high โ measure fTโ |
| โ | fTโ low โ Primary hypothyroidism โ check anti-TPO |
| โ | Anti-TPO positive โ Hashimoto thyroiditis (diagnosis) |
| โ | fTโ normal (TSH high) โ Subclinical hypothyroidism |
โ ๏ธ Common mistake Diagnosing hyperthyroidism from a high total Tโ in a pregnant woman โ that’s โTBG. Check TSH/fTโ first.
โก Differential โ Palpitations, weight loss, heat intolerance
| Step | Path |
|---|---|
| Start | Patient: palpitations, weight loss, tremor โ order TSH |
| โ | TSH low/suppressed โ measure fTโ and fTโ |
| โ | fTโ high โ Overt hyperthyroidism โ check TRAb/TSI ยฑ uptake scan |
| โ | TRAb positive + eye signs โ Graves disease |
| โ | fTโ normal but fTโ high โ T3 toxicosis |
โ ๏ธ Common mistake Stopping at a normal fTโ and calling the patient euthyroid โ you missed T3 toxicosis. Always add fTโ when TSH is suppressed but fTโ is normal.
โข Timing/Marker Selection โ Thyroid cancer follow-up
| Step | Path |
|---|---|
| Start | Post-thyroidectomy for differentiated cancer โ monitor recurrence |
| โ | Order Thyroglobulin (Tg) + anti-Tg antibody together |
| โ | Anti-Tg negative โ Tg reliable โ rising Tg = recurrence |
| โ | Anti-Tg positive โ immunoassay Tg unreliable (false low) โ use LC-MS/MS / trend antibodies |
| โ | If medullary cancer instead โ use calcitonin (+ RET testing), not Tg |
โ ๏ธ Common mistake Trusting a low Tg without checking anti-Tg status โ antibody interference can mask recurrence.
โฃ Method Selection โ Free Tโ: analog vs dialysis
| Step | Path |
|---|---|
| Start | Need free Tโ result |
| โ | Normal binding proteins, routine case โ analog immunoassay (fast, cheap) |
| โ | Abnormal binding (pregnancy, FDH, severe illness) or discordant result โ equilibrium dialysis / ultrafiltration (gold standard) |
โ ๏ธ Common mistake Believing an analog fTโ in a patient with binding-protein abnormalities โ analog assays are still TBG-sensitive; confirm with dialysis.
โค Synthesis Defect โ Perchlorate discharge test
| Step | Path |
|---|---|
| Start | Goiter + suspected synthesis defect โ give radioiodine, then perchlorate |
| โ | Iodide discharged (>10% release) โ organification defect (TPO / Pendrin problem) |
| โ | No uptake to begin with โ NIS (trapping) defect |
โ ๏ธ Common mistake Confusing a trapping (NIS) defect with an organification defect โ perchlorate only discharges iodide that was trapped but not organified.
SECTION 5 โ 25 High-Yield Facts
| # | Fact |
|---|---|
| 1 | TSH is the single most sensitive screening test for primary thyroid dysfunction. |
| 2 | In primary disease, TSH moves opposite to thyroid hormone. |
| 3 | Only ~0.03% of Tโ is free; the rest is bound (mainly to TBG). |
| 4 | Most circulating Tโ comes from peripheral deiodination of Tโ by D1 and D2. |
| 5 | Tโ is the active hormone (higher nuclear-receptor affinity than Tโ). |
| 6 | Estrogen/pregnancy raise TBG โ high total Tโ with normal free Tโ and TSH. |
| 7 | Hashimoto thyroiditis is the most common hypothyroidism cause in iodine-sufficient areas. |
| 8 | Anti-TPO is the sensitive antibody marker for Hashimoto. |
| 9 | Graves disease is the most common cause of thyrotoxicosis in iodine-sufficient areas. |
| 10 | TSI / TRAb (stimulating antibodies) cause Graves disease. |
| 11 | Subclinical hypothyroidism = high TSH with normal fTโ. |
| 12 | Central hypothyroidism = low fTโ with low/normal/slightly high TSH. |
| 13 | T3 toxicosis = suppressed TSH, normal fTโ, elevated fTโ/tTโ. |
| 14 | A 3rd-generation TSH assay has functional sensitivity of 0.01 mIU/L. |
| 15 | Functional sensitivity = the concentration where assay CV < 20%. |
| 16 | Equilibrium dialysis is the gold standard for free Tโ. |
| 17 | Thyroglobulin is the tumor marker for differentiated thyroid cancer; always report anti-Tg status. |
| 18 | Calcitonin is the marker for medullary thyroid carcinoma (C-cell origin, RET). |
| 19 | Papillary carcinoma is the most common, best-prognosis thyroid cancer; anaplastic is the most lethal. |
| 20 | Amiodarone is ~37% iodine by weight and can cause hypo- or hyperthyroidism. |
| 21 | Lithium inhibits thyroid hormone release โ hypothyroidism. |
| 22 | The Wolff-Chaikoff effect = transient synthesis inhibition after an iodine load. |
| 23 | Non-thyroidal illness lowers Tโ first and raises reverse Tโ; avoid testing acutely. |
| 24 | PTU is preferred in the first trimester; radioiodine is contraindicated in pregnancy. |
| 25 | Levothyroxine reaches steady state in ~6 weeks โ recheck TSH no sooner. |
๐ก The single most testable pattern
High total Tโ + normal TSH + normal free Tโ = a binding-protein (TBG) effect, NOT hyperthyroidism. The exam loves the pregnant or estrogen-using patient. Always anchor on TSH and free hormone, never total hormone alone.
High total Tโ + normal TSH + normal free Tโ = a binding-protein (TBG) effect, NOT hyperthyroidism. The exam loves the pregnant or estrogen-using patient. Always anchor on TSH and free hormone, never total hormone alone.
Quick Interpretation Table
| Lab finding | Clinical interpretation |
|---|---|
| โTSH, โfTโ | Primary hypothyroidism (e.g., Hashimoto) |
| โTSH, normal fTโ | Subclinical hypothyroidism |
| โTSH, โfTโ/fTโ | Primary hyperthyroidism (e.g., Graves) |
| โTSH, normal fTโ, โfTโ | T3 toxicosis |
| โfTโ, low/normal TSH | Central hypothyroidism |
| โfTโ, non-suppressed TSH | TSHoma or thyroid hormone resistance |
| โtotal Tโ, normal TSH/fTโ | โTBG (estrogen/pregnancy) โ euthyroid |
๐ด Flashcards โ Active Recall Practice
How to use: Click a card to flip it. Decide honestly โ mark Knew it โ or Review again โ (enabled after you flip). Use ๐ Shuffle to randomize and ๐ Finish any time to see your recall summary.
Card 1of 0
0Knew โ
0Missed โ
Question
โฆ
๐ tap to flip
Answer
โฆ
Recall Summary
0%
๐ Practice Quiz โ Test Your Knowledge
How to use: Each question is a patient scenario. Click an answer to lock it in and get instant feedback with the full explanation and the examiner’s intended trap. Your score appears after all 10.
0 of 10 answered
Quiz Complete
0 / 10
๐ชค Trap Questions โ Beat the Examiner
Harder set (T1โT7). Each targets a misconception examiners love to exploit. Feedback explains the correct reasoning, the trap, why the examiner wrote it, and the wrong answer most students pick.
0 of 7 answered
Trap Set Complete
0 / 7
SECTION 8 โ Rapid Revision Sheet
Numbers
- Free Tโ: ~0.03% of total
- 3rd-gen TSH: 0.01 mIU/L
- Functional sensitivity: CV < 20%
- Levothyroxine steady state: 6 weeks
- Amiodarone: 37% iodine; tยฝ 40ยฑ10 d
- Iodine (pregnancy): 250 ยตg/day
- Severe subclinical hypo: TSH โฅ10
Pattern Associations
- Anti-TPO โ Hashimoto
- TSI/TRAb โ Graves
- Tg โ differentiated cancer
- Calcitonin โ medullary (RET)
- Foramen cecum โ thyroid origin
- โTBG โ estrogen/pregnancy
Opposites (โ vs โ)
- Primary hypo: โTSH / โfTโ
- Primary hyper: โTSH / โfTโ
- Central hypo: โfTโ / low-normal TSH
- TSHoma/RTH: โfTโ / TSH not suppressed
- NTI: โTโ / โrTโ
Confusing Pairs
- Total vs Free Tโ (TBG fools total)
- Hashimoto (destroys) vs Graves (stimulates)
- Tg vs Calcitonin (follicular vs C-cell)
- D2 (activate) vs D3 (inactivate)
- NIS defect vs organification defect
Cancer Quick Hits
- Papillary = most common, best prognosis
- Anaplastic = most lethal
- Medullary = calcitonin + RET
- TSH suppression therapy in DTC
Drugs & Pregnancy
- Lithium โ hypothyroidism
- Phenytoin/carbamazepine โ โTโ
- PTU = 1st trimester; MMI after
- ยนยณยนI contraindicated in pregnancy
- hCG โ โTSH 1st trimester (normal)
SECTION 9 โ Final Memory Map
THE THYROID GLAND
Axis & Hormones
TRH (hypothalamus) โ TSH (pituitary) โ Tโ/Tโ (gland)
Tโ = reservoir; Tโ = active (D1/D2 make it peripherally)
Negative feedback: hormone shuts off TSH (THRฮฒ2)
Transport & Free Hormone
TBG > TTR > albumin; only ~0.03% free
โTBG (estrogen/pregnancy) raises TOTAL, not free
Gold standard free Tโ = equilibrium dialysis
Interpretation Grid (HIGH yield)
โTSH โfTโ = primary hypo ยท โTSH nl fTโ = subclinical
โTSH โfTโ = primary hyper ยท โTSH nl fTโ โfTโ = T3 toxicosis
โfTโ low/nl TSH = central ยท โfTโ non-suppressed TSH = TSHoma/RTH
Autoimmune Disease
Hashimoto โ anti-TPO โ hypo (T-cell destruction)
Graves โ TSI/TRAb โ hyper (eye/skin signs)
Synthesis & Defects
NIS (trap) โ Pendrin (lumen) โ TPO + HโOโ (organify/couple)
Perchlorate discharge โ organification defect
Tumor Markers & Cancer
Tg = differentiated (report anti-Tg) ยท Calcitonin = medullary (RET)
Papillary best ยท Anaplastic worst ยท TSH suppression in DTC
Drugs / Iodine / Pregnancy
Amiodarone 37% iodine ยท Lithium โ hypo ยท PTU 1st trimester
Wolff-Chaikoff = transient block after iodine load